DOCSLIB.ORG

Regulatory T Cells Use Programmed Death 1 Ligands to Directly Suppress Autoreactive B Cells in Vivo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulatory T Cells Use Programmed Death 1 Ligands to Directly Suppress Autoreactive B Cells in Vivo Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo Janine Gotota, Catherine Gottschalka, Sonny Leopolda, Percy A. Knollea, Hideo Yagitab, Christian Kurtsa,1,2, and Isis Ludwig-Portugalla,1,2 aInstitutes of Molecular Medicine and Experimental Immunology (IMMEI), Rheinische Friedrich-Wilhelms-Universität, 53105 Bonn, Germany; and bDepartment of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan Edited by David Tarlinton, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3050, Australia, and accepted by the Editorial Board May 4, 2012 (received for review January 20, 2012) The mechanisms by which regulatory T cells (Tregs) suppress auto- Programmed death-1 (PD-1, CD279) is an activation-induced antibody production are unclear. Here we have addressed this member of the extended CD28/CTLA-4 family that suppresses T question using transgenic mice expressing model antigens in the cells (18–21). It has been associated with exhausted memory kidney. We report that Tregs were essential and sufficient to sup- T cells in chronic viral infection (22, 23) and with cytotoxic T-cell press autoreactive B cells in an antigen-specific manner and to cross-tolerance (24). PD-1 has two known ligands, PDL-1 (B7-H1, prevent them from producing autoantibodies. Most of this sup- CD274) and PDL-2 (B7-DC, CD273) (25, 26), and both of them pression was mediated through the inhibitory cell-surface-mole- are sufficient to mediate T-cell suppression (27, 28). Tregs have cule programmed death-1 (PD-1). Suppression required PD-1 been shown to express PDL-1, but such expression was dispens- expression on autoreactive B cells and expression of the two PD- able for T-cell suppression in vitro (29). Also B cells specific for 1 ligands on Tregs. PD-1 ligation inhibited activation of autoreactive foreign antigens express PD-1 ligands and interact with follicular B cells, suppressed their proliferation, and induced their apoptosis. helper T cells known to express high levels of PD-1, resulting in Intermediate PD-1+ cells, such as T helper cells, were dispensable increased germinal center B-cell survival and plasma cell differ- fi for suppression. These ndings demonstrate in vivo that Tregs use entiation (30). On the other hand, PD-1 knockout mice develop PD-1 ligands to directly suppress autoreactive B cells, and they high levels of auto-Ab (31), which is hard to reconcile with identify a previously undescribed peripheral B-cell tolerance mech- a positive effect on antibody production. Thus, the role of PD-1 on IMMUNOLOGY anism against tissue autoantigens. B cells is unclear. To address these open questions, we have used mice expressing peripheral tolerance | autoimmunity | autoantibodies | inhibitory receptors OVA and HEL in kidney glomerular podocytes (32), which allow detailed studies in an organ where auto-Ab–mediated diseases are utoantibodies (auto-Ab) cause various autoimmune dis- prevalent (33). We demonstrate direct suppression of B cells by Aeases, such as systemic lupus erythematosus and certain Tregs and identify PD-1 signaling as the underlying mechanism. forms of glomerulonephritis. Depletion of autoreactive B cells ameliorates many, but not all, autoimmune diseases. However, Results fi this approach causes severe immunosuppression due to the Tregs Speci cally Suppress Auto-Ab Production Against Glomerular fi general loss of B cells. Specific control of autoreactive B cells is Auto-Ag. To study how Tregs speci cally suppress auto-Ab pro- required for improved therapies. duction against peripheral tissue antigens, we used transgenic mice Regulatory T cells (T ) are powerful suppressors of auto- expressing a membrane-bound fusion protein of OVA and HEL regs under the control of the nephrin promoter in kidney podocytes reactive T cells with high therapeutic potential (1–3). Tregs also suppress auto-Ab production (4, 5). We recently showed in vivo (NOH mice) (32). We used a vaccination scheme of applying OVA in aluminium hydroxide (Alum) three times (experimental scheme that they do so in an antigen-specific (Ag-specific) manner (6, 7). in Fig. 1A), which induced robust anti-OVA titers after 3 wk in These studies used rat insulin promoter HEL/OVA (ROH) mice nontransgenic wild-type (WT) control mice (6, 7). When we vac- expressing ovalbumin (OVA) and hen egg lysozyme (HEL) in cinated NOH mice with this scheme, OVA-specific IgG antibody pancreatic islet β-cells. Autoreactive OVA- and HEL-specificB B fi titers were sevenfold lower compared with WT mice (Fig. 1 ), cells, but not B cells speci c for a foreign antigen, failed to indicating immune tolerance. Consistent with our previous studies proliferate in response to in vivo autoantigen (auto-Ag) challenge on pancreatic auto-Ag (6, 7), treatment with the antibody PC61 1 d and instead underwent apoptosis in a strictly T -dependent + reg before vaccination depleted about 90% of the FoxP3 Tregs (Fig. fashion. Tregs can affect B cells indirectly by suppressing the S1) and restored anti-OVA antibody production in NOH mice to T-helper (Th) cells required for antibody production (8, 9). This 85% of that in WT controls (Fig. 1B). Antibody production against did not rule out that Tregs might also suppress B cells directly. the foreign antigen β-galactosidase (β-Gal) was unchanged in + Cell culture systems have revealed that CD25 Tregs can kill NOH and WT mice, and PC61 treatment had no effect either (Fig. – cocultured B cells (10 12). A recent in vivo study showed that 1C), demonstrating auto-Ag–specific suppression by Tregs. These Tregs enter germinal centers and suppress B cells in this site (13, 14). The question whether this occurred directly or indirectly remained open (15). This question is difficult to address in vivo Author contributions: J.G., C.K., and I.L.-P. designed research; J.G., C.G., S.L., and I.L.-P. performed research; P.A.K. and H.Y. contributed new reagents/analytic tools; J.G., C.G., because it requires an experimental system where Tregs can sup- P.A.K.,H.Y.,C.K.,andI.L.-P.analyzeddata;andJ.G.,C.K.,andI.L.-P.wrotethepaper. press B cells but not Th cells. fl Another open question concerns the molecular mechanisms by The authors declare no con ict of interest. This article is a PNAS Direct Submission. D.T. is a guest editor invited by the which Tregs suppress. In principle, Tregs may suppress other T cells Editorial Board. by (i) secreting inhibitory mediators; (ii) deprivation of survival 1C.K. and I.L.P. contributed equally to this study. factors; (iii) killing target cells by granzyme/perforin; and (iv) 2To whom correspondence may be addressed. E-mail: [email protected] or isis.ludwig- modulation of DCs by ligating inhibitory T-cell receptors (16, 17). [email protected]. The exact contribution of these mechanisms in relevant in vivo This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. situations and the mechanisms by which Tregs suppress are unclear. 1073/pnas.1201131109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1201131109 PNAS Early Edition | 1of6 Downloaded by guest on September 30, 2021 Fig. 1. Blocking PD-1 restores Ag-specific auto- Ab titers in vivo. (A) Experimental scheme for B and C:miceweredepletedofTregs with PC61 Ab on days −4, −1, 6, and 13 (white arrows) and immunized with 10 μgOVAand10μg β-Gal in Alum on days 0, 7, and 14 (black arrows). (B and C) IgG titers against OVA (B)andβ-Gal (C)in NOH (black bars) or nontransgenic wild-type (WT) control mice (white bars) after depletion of Tregs on day 21. (D) Experimental scheme for E and F: mice were depleted of Tregs with PC61 Ab on days −4and−1 and immunized with OVA/Alum on day 0. (E and F)Percentage(E) and mean fluorescence intensity (MFI) (F)ofPD- 1+ OVA-specific B cells on day 3. (G) Experi- mental scheme for H and I: mice were immu- nizedondays0,7,and14andinjectedwithPD- 1–blocking RMP1-14 or isotype control Abs on thesamedays.(H) Anti-OVA serum IgG titers on day 21 in WT mice (white bar), NOH mice (black bar), NOH mice treated with RMP1-14 (light gray bar), or with isotype control (dark gray bar). (I) Anti-NP titers on day 14 in NOH (black bars) or WT (white bars) mice immunized with either OVA-NP or BSA-NP in Alum. *P < 0.05; **P < 0.01; ***P < 0.001 (ANOVA and Bonfer- roni). Data are representative of two experi- ments using three to four mice in each group. findings indicate that Tregs prevent autoreactive B cells from by central tolerance mechanisms. To address this possibility, we producing anti-glomerular auto-Ab. immunized these mice with OVA-nitrophenol (NP) or BSA-NP as a control and determined the response of NP-specific B cells. PD-1 Mediates Peripheral B-Cell Tolerance Against Glomerular Auto- Such B cells were not autoreactive yet still were controlled by Ag. To identify candidate molecules for B-cell suppression, we OVA-specific Th cells or Tregs. NP-specific antibody serum titers isolated OVA-specific B cells (representative FACS plot in Fig. in NOH mice were 2.8-fold lower than in WT control mice after S2) from immunized NOH or WT mice and determined ex- immunization with OVA-NP, but were unchanged when mice pression of molecules previously implicated in peripheral im- were immunized with NP-BSA (Fig. 1I). When PD-1 was mune tolerance, such as PD-1 or Fas (11, 18, 34). OVA blocked, anti-NP titers were restored to 67% of those in WT vaccination increased PD-1 mRNA expression in OVA-specific controls, which was not significantly different (Fig.
Load more

Recommended publications
  • SAHLGRENSKA AKADEMIN Thymic Studies
    Göteborg, 2019 Thymic studies Investigations into the effects of childhood thymectomy, and characterization of thymic B cells and Hassall's corpuscles Akademisk avhandling Som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin, Göteborgs universitet kommer att offentligen försvaras i föreläsningssalen våning 3, Guldhedsgatan 10A, Göteborg Tisdagen den 14e maj, klockan 13.00 av Christina Lundqvist Fakultetsopponent: Professor Ludger Klein Ludwig-Maximilians-Universität, Tyskland Avhandlingen baseras på följande delarbeten I. Gudmundsdottir J*, Lundqvist C*, Ijspeert H, van der Slik E, Óskarsdóttir S, Lindgren S, Lundberg V, Berglund M, Lingman-Framme J, Telemo E, van der Burg M, Ekwall O. T-cell receptor sequencing reveals decreased diversity 18 years after early thymectomy. J Allergy Clin Immunol. 2017 Dec;140(6):1743- 1746.e7. doi: 10.1016/j.jaci.2017.08.002. Epub 2017 Sep 1. * These authors contributed equally to this work. II. Lundqvist C*, Camponeschi A*, Visentini M, Telemo E, Ekwall O‡, Mårtensson IL‡. Switched CD21-/low B cells with an antigen-presenting phenotype in the infant thymus. J Allergy Clin Immunol. 2018 Nov 30. pii: S0091-6749(18)31721- 4. doi: 10.1016/j.jaci.2018.11.019. * These authors contributed equally to this work. ‡ These authors contributed equally to this work. III. Lundqvist C, Lindgren S, Cheuk S, Lundberg V, Berglund M, Thörn K, Telemo E, Ekwall O. Characterization of Hassall's corpuscles in the human thymus. Manuscript SAHLGRENSKA AKADEMIN INSTITUTIONEN FÖR MEDICIN Göteborg, 2019 Thymic studies Investigations into the effects of childhood thymectomy, and characterization of thymic B cells and Hassall's corpuscles Christina Lundqvist Avdelningen för reumatologi och inflammationsforskning, Institutionen för medicin, Sahlgrenska akademin, Göteborgs universitet Abstract This thesis focuses on the human thymus, a primary lymphoid organ responsible for the maturation of T cells.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Of T Cell Tolerance
    cells Review Strength and Numbers: The Role of Affinity and Avidity in the ‘Quality’ of T Cell Tolerance Sébastien This 1,2,† , Stefanie F. Valbon 1,2,†, Marie-Ève Lebel 1 and Heather J. Melichar 1,3,* 1 Centre de Recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada; [email protected] (S.T.); [email protected] (S.F.V.); [email protected] (M.-È.L.) 2 Département de Microbiologie, Immunologie et Infectiologie, Université de Montréal, Montréal, QC H3C 3J7, Canada 3 Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: The ability of T cells to identify foreign antigens and mount an efficient immune response while limiting activation upon recognition of self and self-associated peptides is critical. Multiple tolerance mechanisms work in concert to prevent the generation and activation of self-reactive T cells. T cell tolerance is tightly regulated, as defects in these processes can lead to devastating disease; a wide variety of autoimmune diseases and, more recently, adverse immune-related events associated with checkpoint blockade immunotherapy have been linked to a breakdown in T cell tolerance. The quantity and quality of antigen receptor signaling depend on a variety of parameters that include T cell receptor affinity and avidity for peptide. Autoreactive T cell fate choices (e.g., deletion, anergy, regulatory T cell development) are highly dependent on the strength of T cell receptor interactions with self-peptide. However, less is known about how differences in the strength Citation: This, S.; Valbon, S.F.; Lebel, of T cell receptor signaling during differentiation influences the ‘function’ and persistence of anergic M.-È.; Melichar, H.J.
    [Show full text]
  • B Lymphocytes in Neuromyelitis Optica
    VIEWS & REVIEWS B lymphocytes in neuromyelitis optica Jeffrey L. Bennett, MD, ABSTRACT PhD Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the CNS that predomi- ’ Kevin C. O Connor, PhD nantly affects the spinal cord and optic nerves. A majority (approximately 75%) of patients with Amit Bar-Or, MD, FRCP NMO are seropositive for autoantibodies against the astrocyte water channel aquaporin-4 Scott S. Zamvil, MD, (AQP4). These autoantibodies are predominantly IgG1, and considerable evidence supports their PhD pathogenicity, presumably by binding to AQP4 on CNS astrocytes, resulting in astrocyte injury Bernhard Hemmer, MD and inflammation. Convergent clinical and laboratory-based investigations have indicated that Thomas F. Tedder, PhD B cells play a fundamental role in NMO immunopathology. Multiple mechanisms have been H.-Christian von hypothesized: AQP4 autoantibody production, enhanced proinflammatory B cell and plasmablast Büdingen, MD activity, aberrant B cell tolerance checkpoints, diminished B cell regulatory function, and loss of Olaf Stuve, MD, PhD B cell anergy. Accordingly, many current off-label therapies for NMO deplete B cells or modulate Michael R. Yeaman, PhD their activity. Understanding the role and mechanisms whereby B cells contribute to initiation, Terry J. Smith, MD maintenance, and propagation of disease activity is important to advancing our understanding Christine Stadelmann, of NMO pathogenesis and developing effective disease-specific therapies. Neurol Neuroimmunol MD Neuroinflamm 2015;2:e104;
    [Show full text]
  • B Cells + Interaction
    Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5 + B Cells This information is current as of October 2, 2021. Isaac R. Blanca, Earl W. Bere, Howard A. Young and John R. Ortaldo J Immunol 2001; 167:6132-6139; ; doi: 10.4049/jimmunol.167.11.6132 http://www.jimmunol.org/content/167/11/6132 Downloaded from References This article cites 45 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/167/11/6132.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5؉ B Cells Isaac R. Blanca,*† Earl W. Bere,* Howard A.
    [Show full text]
  • The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M
    The Importance of Dendritic Cells in Maintaining Immune Tolerance Cindy Audiger, M. Jubayer Rahman, Tae Jin Yun, Kristin V. Tarbell and Sylvie Lesage This information is current as of October 1, 2021. J Immunol 2017; 198:2223-2231; ; doi: 10.4049/jimmunol.1601629 http://www.jimmunol.org/content/198/6/2223 Downloaded from References This article cites 166 articles, 73 of which you can access for free at: http://www.jimmunol.org/content/198/6/2223.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Th eJournal of Brief Reviews Immunology The Importance of Dendritic Cells in Maintaining Immune Tolerance x { Cindy Audiger,*,†,1 M. Jubayer Rahman,‡,1 Tae Jin Yun, , Kristin V. Tarbell,‡ and Sylvie Lesage*,† Immune tolerance is necessary to prevent the immune specific depletion of CD11c+ cells (3).
    [Show full text]
  • Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Equirr Es Interleukin 27 Signaling in Dendritic Cells
    Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology 10-27-2017 Induction of peripheral tolerance in ongoing autoimmune inflammation equirr es interleukin 27 signaling in dendritic cells Rodolfo Thome Thomas Jefferson University Jason N. Moore Thomas Jefferson University Elisabeth R. Mari Thomas Jefferson University Javad Rasouli Thomas Jefferson University Follow this and additional works at: https://jdc.jefferson.edu/neurologyfp Part of the Medical Immunology Commons, and the Neurology Commons Let us know how access to this document benefits ouy Recommended Citation Thome, Rodolfo; Moore, Jason N.; Mari, Elisabeth R.; and Rasouli, Javad, "Induction of peripheral tolerance in ongoing autoimmune inflammation equirr es interleukin 27 signaling in dendritic cells" (2017). Department of Neurology Faculty Papers. Paper 139. https://jdc.jefferson.edu/neurologyfp/139 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Neurology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. ORIGINAL RESEARCH published: 27 October 2017 doi: 10.3389/fimmu.2017.01392 Induction of Peripheral Tolerance in Ongoing autoimmune inflammation Requires Interleukin 27 Signaling in Dendritic Cells Rodolfo Thomé1, Jason N.
    [Show full text]
  • Advanced Laboratory Studies for Primary Immunodeficiency Disorders
    4813: Problem-based Learning Workshop Advanced Laboratory studies for Primary Immunodeficiency Disorders Moderator: Richard Wasserman, MD, PhD Discussion Leader: Roshini Abraham, PhD ● Understand B cell flow analysis in CVID (PBL case) HUMAN PERIPHERAL B CELL DIFFERENTIATION Marginal zone B cells Bone marrow Immature B cells Transitional B cells Naïve B cells Memory B cells Plasmablasts Periphery MARKERS FOR PERIPHERAL B CELL SUBSETS - CURRENT Total B cells: CD19 and/or CD20 Transitional B cells: CD19+CD38+IgM+ Total IgM+ B cells: CD19+IgM+ (includes naïve B cells) Memory B cells: CD19+CD27+ switched memory B cells: CD19+CD27+IgM-IgD- marginal zone B cells: CD19+CD27+IgM+IgD+ IgM-only memory B cells: CD19+CD27+IgM+IgD- Plasmablasts: CD19+CD38+IgM- CD21+ B cells: CD19+CD21+ CD21- B cells: CD19+CD21- ● With newer information, more suitable cellular markers are available for accurate identification of transitional B cells and plasmablasts, in particular, but also for naïve B cells NEWER B CELL MARKERS FOR B CELL SUBSET QUANTITATION Total B cells and B cell subsets can be quantitated in blood using multicolor flow cytometry: Total B cells: CD45+CD19+20+ For B cell subset analysis, the gating strategy uses CD45+19+20+/- (depending on the subset being studied), thus these markers are not specifically repeated in the panel below:- Transitional B cells: T1: CD24hi38hi10+27-21lowIgM+++ T2: CD24hi38hi10+27-21int IgM+++ Naïve B cells: IgM+IgD+27-38-21+++ Memory B cells: Marginal zone B cells: CD27+IgM+IgD+ IgM-only memory: CD27+IgM+IgD- IgD-only
    [Show full text]
  • Immune Regulation and Tolerance
    Mechanisms of unresponsiveness: Immunological Ignorance Immune Regulation Normal response and Proliferation and Tolerance differentiation Mechanisms of Antigen/lymphocyte barrier unresponsiveness Mechanisms of Tissue abnormalities contributing to release and Yong-Rui Zou (Oct. 2005) autoimmunity presentation of self antigens. [email protected] Disease models Sympathetic ophthalmia, experimental allergic encephalomyelitis (EAE) Immunoregulation: A balance between activation and Mechanisms of unresponsiveness: suppression of effector cells to achieve an efficient Central tolerance in B and T cells (I): Clonal Deletion immune response without damaging the host. Self antigen presented in generative Activation (immunity) Suppression (tolerance) lymphoid Deletion of immature organs lymphocytes strongly recognizing self antigens autoimmunity immunodeficiency present in generative organs Lymphoid precursor Significance: The induction of tolerance may be Survival of clones which are only moderately exploited to prevent graft rejection, to treat autoimmune responsive to self antigens and allergic diseases, and to prevent immune responses present in generative in gene therapy. organs; forms T/B cell repertoire Important features of immunoregulation: 1. Antigen specific; affects T or B lymphocytes Science 298:1395 (2002) 2. Tolerance vs. activation? Determined by the nature of antigen and associated stimuli, and when and where the antigen is encountered Immunity 23:227 (2005) 1 Mechanisms of unresponsiveness: AIRE: Autoimmune regulator. Peripheral tolerance in B cells (I): Anergy Immunogenic signaling Tolerogenic signaling • Transcription factor. • Expressed at a high level by thymic medullar epithelium Acute Chronic cells. antigens antigens CD40L • Autosomal recessive mutation leads to autoimmune LPS polyendocrine syndrom - type 1 (APS-1). CD40 CD40 TLR4 • Inactivation of aire abolishes expression of some tissue TLR4 BCR BCR Fcγ2b specific genes in the thymic medulla.
    [Show full text]
  • Type 1 Regulatory T Cells: a New Mechanism of Peripheral Immune Tolerance
    Cellular & Molecular Immunology (2015) 12, 566–571 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi REVIEW Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance Hanyu Zeng, Rong Zhang, Boquan Jin and Lihua Chen The lack of immune response to an antigen, a process known as immune tolerance, is essential for the preservation of immune homeostasis. To date, two mechanisms that drive immune tolerance have been described extensively: central tolerance and peripheral tolerance. Under the new nomenclature, thymus-derived regulatory T (tTreg) cells are the major mediators of central immune tolerance, whereas peripherally derived regulatory T (pTreg) cells function to regulate 1 peripheral immune tolerance. A third type of Treg cells, termed iTreg, represents only the in vitro-induced Treg cells . Depending on whether the cells stably express Foxp3, pTreg, and iTreg cells may be divided into two subsets: the classical 1 1 1 2 2 CD4 Foxp3 Treg cells and the CD4 Foxp3 type 1 regulatory T (Tr1) cells . This review focuses on the discovery, associated biomarkers, regulatory functions, methods of induction, association with disease, and clinical trials of Tr1 cells. Cellular & Molecular Immunology (2015) 12, 566–571; doi:10.1038/cmi.2015.44; published online 8 June 2015 Keywords: biomarkers; clinical trials; regulatory functions; type 1 regulatory T cells INTRODUCTION functions of these cells and ultimately to apply this knowledge The induction and formation of peripheral immune tolerance to the treatment of associated diseases. is essential to maintaining stability of the immune system. In addition to the immune system’s major roles in regulating THE DISCOVERY OF TR1 CELLS clonal deletion, antigen sequestration, and expression at privi- Tr1 cells were first described by Roncarolo et al.
    [Show full text]
  • The Anatomy of T-Cell Activation and Tolerance Anna Mondino*T, Alexander Khoruts*, and Marc K
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2245-2252, March 1996 Review The anatomy of T-cell activation and tolerance Anna Mondino*t, Alexander Khoruts*, and Marc K. Jenkins Department of Microbiology and the Center for Immunology, University of Minnesota Medical School, 420 Delaware Street S.E, Minneapolis, MN 55455 ABSTRACT The mammalian im- In recent years, it has become clear that TCR is specific for a self peptide-class I mune system must specifically recognize a full understanding of immune tolerance MHC complex) T cell that will exit the and eliminate foreign invaders but refrain cannot be achieved with reductionist in thymus and seed the secondary lymphoid from damaging the host. This task is vitro approaches that separate the individ- tissues (3, 4). In contrast, cortical CD4+ accomplished in part by the production of ual lymphocyte from its in vivo environ- CD8+ thymocytes that express TCRs that a large number of T lymphocytes, each ment. The in vivo immune response is a have no avidity for self peptide-MHC bearing a different antigen receptor to well-organized process that involves mul- complexes do not survive and die by an match the enormous variety of antigens tiple interactions of lymphocytes with each apoptotic mechanism. Cortical epithelial present in the microbial world. However, other, with bone-marrow-derived antigen- cells are essential for the process of pos- because antigen receptor diversity is gen- presenting cells (APCs), as well as with itive selection because they display the self erated by a random mechanism, the im- nonlymphoid cells and their products. The peptide-MHC complexes that are recog- mune system must tolerate the function of anatomic features that are designed to op- nized by CD4+ CD8+ thymocytes and also T lymphocytes that by chance express a timize immune tolerance toward innocuous provide essential differentiation factors self-reactive antigen receptor.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]